Journal
FUTURE CARDIOLOGY
Volume 8, Issue 1, Pages 71-88Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/FCA.11.79
Keywords
management and therapy; mitochondria; mitochondrial cardiomyopathy; nuclear and mtDNA; red flags
Categories
Ask authors/readers for more resources
The mitochondrion is the main site of production of ATP that represents the source of energy for a large number of cellular processes. Mitochondrial diseases that result in a deficit in ATP production can affect almost every organ system with a large spectrum of clinical phenotypes. Cardiomyocytes are particularly vulnerable to limited ATP supply because of their large energy requirement. Abnormalities in the mitochondrial function are increasingly recognized in association with dilated and hypertrophic cardiomyopathy, cardiac conduction defects, endothelial dysfunction and coronary artery disease. Cardiologists should, therefore, be alerted to symptoms and signs suggestive of mitochondrial diseases and become familiar with the general issues related to multisystem disease management, genetic counseling and testing.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available